Skip to main content
. 2018 Apr 17;9(29):20590–20604. doi: 10.18632/oncotarget.25020

Figure 3.

Figure 3

Response of aGVHD within the 90 days after initiation of MSC therapy according to (A) MSC dose for first infusion and (B) aGVHD grade.